334 shares of its common stock at a price per share of $0.

Chardan Capital Markets, LLC acted as the exceptional placement agent for the transaction. Roth Capital Partners served as the economic advisor to CEL-SCI in the purchase. All the securities were provided pursuant to an effective shelf registration statement. A shelf registration statement associated with the shares of common share and warrants issued in the offering offers been filed with, and declared effective by, the Securities and Exchange Commission . A prospectus supplement relating to the offering provides been filed with the SEC. Electronic copies of the prospectus product and accompanying prospectus may be obtained at the SEC’s website at.. CEL-SCI closes previously announced registered direct offering CEL-SCI Corporation declared today that it has shut its previously announced authorized direct offering for the sale of 13,333,334 shares of its common stock at a price per share of $0.30 and warrants to get up to 12,000,000 shares of CEL-SCI Corporation’s common stock at a purchase price of $0.40.More than a six-month period, sufferers who tested their personal blood sugar amounts decreased HbA1c by about 0.3 %. This effect nearly totally dissipated after 12 a few months. Related StoriesSleep reduction reduces insulin sensitivity, raises diabetes riskProduction of insulin determines achievement rate of weight reduction surgeryVaccination against type 1 diabetes may quickly be available to youthful childrenAdditionally, the review demonstrated that bloodstream sugar self-monitoring experienced no influence on patients’ fulfillment, general well becoming, or general health-related standard of living. One research, which compared the expense of the first yr of monitoring bloodstream for glucose versus urine screening, found that monitoring blood sugar was 12 situations more costly.